The purpose of the Center for Medicinal Cannabis Research is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.

news



DEA Says Pot to Remain Illegal Drug

Rob Hotakainen, San Diego Union Tribune, August 12, 2016

Delivering a major blow to backers of pot legalization, the Obama administration said Thursday that it would keep marijuana classified as one of the nation's most dangerous drugs, similar to heroin and LSD.

The long-awaited decision by the U.S. Drug Enforcement Administration keeps intact a 1970 law that lists marijuana as Schedule 1 drug, one defined as having no medical value. That runs counter to decisions made by California and 25 other states that have already approved use of the drug as medicine.

Read the full story...


DEA moves to make more marijuana available for medical research

Peter Hecht and Christopher Cadelago, The Sacramento Bee, August 11, 2016

Federal authorities Thursday announced they were standing firm on a 46-year-old policy of classifying marijuana as a dangerous narcotic with no accepted medical use.

But in a seemingly contradictory decision, the Drug Enforcement Administration also said it was lifting long-standing restrictions on cultivation to facilitate research of marijuana’s potential effectiveness as medicine for a range of conditions. That decision will end a restrictive monopoly, in which the only marijuana federally sanctioned for medical studies was grown under a government contract with the University of Mississippi.

Read the full story...


What Pain Specialists Need to Know About Medicinal Cannabis

Lisa Ellis, Practical Pain Management, August 1, 2016

An interview with Barth Wilsey, MD

A growing number of states have approved medical marijuana (cannabis) to treat a variety of conditions, including neuropathic pain, spasticity, and pediatric epilepsy. Despite the increasing popularity of these treatments, there’s been an absence of uniform standards and guidelines in place to help medical professionals navigate the rapidly changing landscape in the most effective way. As a result, many pain specialists are left grappling with a host of important issues when it comes to incorporating cannabis into a broader pain treatment strategy. Here is some insight from an experienced practitioner on treating pain with cannabis.

Read the full story...


More News

Click here to access the CMCR news archives.



Igor Grant, MD

American Psychological Association Plenary Address: Marijuana as Medicine: Can we see past the smoke?
Denver, CO (August 2016)




Barth Wilsey, MD

Marijuana and Cannabinoids: A Neuroscience Research Summit;
Bethesda, MD (March 2016)



THE PSYCHIATRIC AND NEUROCOGNITIVE EFFECTS OF CANNABIS
(PDF)

Igor Grant, MD, FRCP(C) American Association for the Advancement of Science Annual Meeting

McGill University Health Centre - Research Institute
(February 2015)



Copyright © 2016 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego
cmcr@ucsd.edu | HNRP |